Metropolitan Life Insurance Company (MetLife)’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,589	Closed	-$87.4K	–	2459
2023 Q1	$87.4K	Sell	11,589 -1,321	-10%	-$9.96K	﹤0.01%	1065
2022 Q4	$131K	Buy	12,910 +238	+2%	+$2.41K	0.01%	923
2022 Q3	$125K	Hold	12,672	–	–	0.01%	888
2022 Q2	$135K	Buy	+12,672	New	+$135K	0.01%	898